Next Specialty "Unlocking Nature's Secrets"

The NJSBDC Technology Commercialization Program

Next Specialty is a woman owned life sciences company that is developing new plant derived, healthy and environmentally friendly molecules for skin care, environmental remediation, treatment of diseases and other commercial applications.  In the course of its research, the company has identified six plant products that have antioxidants, ultraviolet (UV) light absorption and sunless skin tanning properties far superior to the synthetic chemicals used in today's sunscreen and other personal care formulations.  However, before these products can be commercialized, the active ingredients responsible for these desirable properties must be isolated, separated from the rest of the product, identified and extensively tested.

Next Speciality was founded in 2007 by a group of scientists led by Dr. Namita Deo and backed by a $ 350,000 angel investment.  Dr. Deo has more than 15 years of experience in colloids and surface science, biotechnology and surfactants and skin care applications.  Next Specialty leased a wet lab in the New Jersey Institute of Technology (NJIT) Enterprise Development Center (EDC) business incubator in Newark.  In June of 2008 EDC Executive Director Jerry Creighton engaged NJSBDC Technology Commercialization consultant Randy Harmon to assist Namita with federal Small Business Innovation Research (SBIR) R &D grant proposals targeted to the National Institutes of Health and National Science Foundation.  Those initial efforts were unsuccessful, but instructive.

During this period, Dr. Deo attended SBIR training seminar, through which she became eligible for cost shared proposal preparation assistance.  Through this service, attendees pay approximately 25 % of the cost of a written critique and assistance in strengthening a draft proposal, with the balance of the cost paid by NJCST and NJSBDC.  Namita's EDC incubator paid the cost share and Randy Harmon assisted her in rethinking and rewriting her rejected NSF proposal, which was resubmitted in June 2009.  A few days before Thanksgiving 2009, Next Specialty received notice of a $ 150,000 Phase I award.

The goal of this project is to isolate the active molecules in Next Specialty's most promising plant extract and to conduct preliminary testing of these molecules.  In April, through the support of the EDC, Randy helped Dr. Deo submit an NSF SBIR Phase 1B proposal.  In July, she received notice of a $ 50,000 Phase 1B award, which will help her conduct toxicity and stability testing.  It confirms NSF's interest in the project, and can be seen as significantly improving the prospects for a $ 500,000 Phase II award next year.

According to Dr. Deo, "Mr. Harmon's help has been invaluable and one of the keys to Next Specialty's success. We will continue to need help and support to prepare critical upcoming proposals." In addition to NJSBDC's assistance Next Specialty has participated in the EDC's "Get Ready for Funding" Program including suck things as commercialization training, business plan reviews, business and presentation coaching and the opportunity to present to angel investors.

Contact: Dr. Namita Deo, Next Specialty EDC 211 Warren Street Newark, NJ 07103 973-621-0800 www.ngtechscrd.com

---

NJIT New Jersey Institute of Technology

Federal Support for EDC Health Care Innovators

NEWARK, Nov. 16, 2010--Five technology based high-tech ventures that have achieved success in the health care field with the assistance of NJIT’s Enterprise Development Center (EDC) www.njit-edc.org  are the recipients of more than a million dollars in funding awarded in 2009 and 2010 under the federal program “Qualifying Therapeutic Discovery Project Grants for the State of New Jersey.”

The Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services, approved applications from companies having no more than 250 employees for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness. The IRS determined the amount to be awarded to each company.

“The EDC providing mentoring to enable our life science companies to participate in this federal program, said Judith Sheft, associate vice president  technology development at NJIT.  “We made the companies aware of the opportunity, arranged for a seminar featuring tax accounting experts and helped companies prepare their applications.  The outcome encouraged us all.”

Companies receiving the award, all based at EDC, were

Edge Therapeutics, Inc. http://edgetherapeutics.com/  transforms well-established off-patent drugs into targeted, locally delivered therapies that address medical conditions in the central nervous system.

Healthy Functions, LLC http://www.healthyfunctions.com/ develops state-of-the-art support surfaces to help prevent and treat pressure ulcers.

HiLin Life Products, Inc. http://hilinlife.com/management.html offers products and services that improve women's reproductive health.

Urovalve Inc’s http://www.urovalve.com/home.php mission is to design, develop and commercialize superior medical devices that address serious problems with urinary flow and control.

Samos Pharmaceuticals, LLC, an EDC graduate now headquartered in Kendall Park, has developed a platform technology that allows for the oral or parenteral delivery of drugs over a several-day period, such as 7 days or 30 days, with the administration of a single pill or capsule.

The EDC is New Jersey’s largest high-technology business incubator, and one of the largest in the nation. The over 90 companies presently housed at the EDC employ some 300 people. They have attracted more than $55 million in third-party funding and have had revenues of approximately $40 million.

---

Reva, Inc. & iSpeech Makes it to NJBIZ 40 under 40

Hitesh Desai, Reva, Inc & Heath Ahrens, iSpeech, both EDC Client Companies, made it to NJBIZ's 2011 40 under 40 from dreamers to leaders. 

---

Menssana Research Inc. Receives $4.2 Million BARDA Contract to Develop a Breathalyzer Test for Radiation Exposure

NEWARK, Sept. 22, 2010--The Biomedical Advanced Research and Development Authority (BARDA) in the US Department of Health and Human Services has awarded Menssana Research Inc., a company with research facilities in the NJIT Enterprise Development Center, a contract for $4.2 million to develop a breath test for radiation exposure.  If the contract is exercised with options, it could total $22.84 million. 

Menssana Research has developed a sensitive breathalyzer which can detect several hundred different chemical compounds in normal human breath. The breathalyzer is much more sensitive than those police use to measure blood alcohol concentrations, and is currently in studies to identify disease biomarkers in patients with lung cancer, breast cancer, and tuberculosis. A pilot study also identified biomarkers of radiation exposure in cancer patients receiving radiation therapy. The Menssana breathalyzer is safe, painless and non-invasive, and only requires a person to breathe gently into a mouthpiece for two minutes. Potentially, it could provide a rapid and reliable diagnostic test to screen large numbers of casualties.

A radiologic or nuclear event such as an accident involving radioactive materials or a "dirty bomb" explosion could injure a large number of people. Emergency responders would need to rapidly screen and identify those who have been exposed to radiation. This will require a new kind of screening test to measure radiation effects on the human body.

This new breath test for biomarkers of radiation exposure will be evaluated in patients receiving radiation as part of their normal scheduled treatment. Five medical centers will participate in the study, including Christiana Health Care System in Delaware, MD; Anderson Medical Center in Orlando, Florida; New York University Langone Medical Center; Seattle Swedish Cancer Institute; and the Veterans Administration Medical center at the University of California Los Angeles (UCLA). In addition, the Applied Physics Laboratory at Johns Hopkins University will evaluate breath testing in animals, the LECO Corporation in St. Joseph, Michigan will provide advanced instruments to analyze the breath samples, and American Westech, Inc, of Harrisburg, Pennsylvania will provide analytical and consultative services.

The project's long-term goal is to develop a point-of-care breathalyzer that could be used to rapidly screen large numbers of people for radiation exposure, and to determine the severity of the dose received in order to guide their medical care.

NJIT, New Jersey's science and technology university,enrolls more than 8,800 students pursuing bachelor's, master's and doctoral degrees in 120 programs. The university consists of six colleges: Newark College of Engineering, College of Architecture and Design, College of Science and Liberal Arts, School of Management, College of Computing Sciences and Albert Dorman Honors College. U.S. News & World Report's 2009 Annual Guide to America's Best Colleges ranked NJIT in the top tier of national research universities. NJIT is internationally recognized for being at the edge in knowledge in architecture, applied mathematics, wireless communications and networking, solar physics, advanced engineered particulate materials, nanotechnology, neural engineering and e-learning. Many courses and certificate programs, as well as graduate degrees, are available online through the Office of Continuing Professional Education.

Contact: Michael Phillips, MD, Menssana Research, Inc 1 Horizon Road, Suite 1415, Fort Lee, Phone and fax: 201 886-7004 www.menssanaresearch.com  

---

NJIT New Jersey Institute of Technology

Federal Support for EDC Health Care Innovators

NEWARK, Nov. 16, 2010--Five technology based high-tech ventures that have achieved success in the health care field with the assistance of NJIT’s Enterprise Development Center (EDC) www.njit-edc.org  are the recipients of more than a million dollars in funding awarded in 2009 and 2010 under the federal program “Qualifying Therapeutic Discovery Project Grants for the State of New Jersey.”

The Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services, approved applications from companies having no more than 250 employees for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness. The IRS determined the amount to be awarded to each company.

“The EDC providing mentoring to enable our life science companies to participate in this federal program, said Judith Sheft, associate vice president  technology development at NJIT.  “We made the companies aware of the opportunity, arranged for a seminar featuring tax accounting experts and helped companies prepare their applications.  The outcome encouraged us all.”

Companies receiving the award, all based at EDC, were

Edge Therapeutics, Inc. http://edgetherapeutics.com/  transforms well-established off-patent drugs into targeted, locally delivered therapies that address medical conditions in the central nervous system.

Healthy Functions, LLC http://www.healthyfunctions.com/ develops state-of-the-art support surfaces to help prevent and treat pressure ulcers.

HiLin Life Products, Inc. http://hilinlife.com/management.html offers products and services that improve women's reproductive health.

Urovalve Inc’s http://www.urovalve.com/home.php mission is to design, develop and commercialize superior medical devices that address serious problems with urinary flow and control.

Samos Pharmaceuticals, LLC, an EDC graduate now headquartered in Kendall Park, has developed a platform technology that allows for the oral or parenteral delivery of drugs over a several-day period, such as 7 days or 30 days, with the administration of a single pill or capsule.

The EDC is New Jersey’s largest high-technology business incubator, and one of the largest in the nation. The over 90 companies presently housed at the EDC employ some 300 people. They have attracted more than $55 million in third-party funding and have had revenues of approximately $40 million.           

---

            Training and Health Information Sent via Cell Phone ARRA Success Story

In today's world of information overload and short attention spans, a small New Jersey information technology company, using a Recovery Act grant from NIEHS, saw a way to cut through the clutter to get urgently needed information right to the people who need it, using something nearly everyone is carrying with them — a cell phone.

Using the same technology that enables e-mail or notifications from Facebook or Twitter to pop up on a smart phone, BanDeMar Networks is developing a version of this "push" technology to deliver on-the-spot training to workers at emergency sites.

BanDeMar calls the concept Just-in-Time Training for Emergency Incidents System (JITTEIS). "Just-in-Time Training is a type of distance learning," says company founder Cesar Bandera, Ph.D., "but instead of being in the classroom, it's actually given to the person in the field who needs the information right then and there."

"The tricky part," Bandera continues, "was to come up with a way the videos could be sent to any phone, no matter how old and no matter what the carrier."

The first big test of the technology came during an April 2010 terrorism training exercise in Philadelphia that simulated a dirty bomb attack. Of the 500 participants, many were HAZMAT workers needing training in dealing with radiological hazards. BanDeMar was able to send its JITTEIS videos to these workers and create new ones on the fly.

Next, the JITTEIS concept was put into action in Haiti  (http://www.youtube.com/watch?v=WaaV3Ae3dnc), informing medical workers on the correct way to rehydrate cholera patients, and saving lives for real. Also, Gulf oil spill cleanup workers have received safety information via JITTEIS.

And that's just the beginning for BanDeMar Networks. Plans include using the system to send potentially life-saving information from NIEHS to vulnerable populations, such as those living near a Superfund site. "Anyone can forward JITTEIS messages to friends and family," Bandera continues. "It's like Twitter but with videos."

---

    EDC Company Edge Therapeutics

            in

BioCentury

March 14, 2011 (BioCentury, The Berstein Report on BioBusiness)

Edge Therapeutics, a compnay based out of the Enterprise Development Center, located on the New Jersey Institute of Technology Campus, is mentioned in this month's BioCentury, The Bernstein Report on BioBusiness.

Edge Therapeutics, is prominently featured as "Emerging Company Profile". Edge's product, NimoGel nimodipine, a locally delivered oral generic drug, is the only drug approved to prevent delayed complications of brain hemorrhage. For two weeks following a subarachnoid hemorrhage, patients are susceptible to cerebral vasospasm, which limited blood flow to the brain and can cause ischemic strokes and additional tissue damage.  Nimodipine inhibits calcium ion transfer into smooth muscle, thus preventing contraction of smooth vascular muscle in the brain.

Edge believes delivering nimodipine directly to the site of the injury will allow a more efficacious dose to be used.  NimoGel (EG-1961) uses a biodegradable microparticle drug delivery system from SurModics, Inc.

According to Edge President and CEO Brian Leuthner, the microparticle system allows sustained, consistent release of nimodipine over the 14 days following initial injury.

Edge expects nimodipine's well-established safety profile will likely enable the company to advance from pre-clinical work straight into Phase II studies in 2012.

---

EDC Company is Honored at NJTC Venture Conference 2011

Xipto, Inc. was recently honored at the NJTC Venture Conference, which had taken on March 25, 2011 at The Palace at Somerset Park, Somerset, New Jersey. Xipto, Inc. received the "Company Most Likely to have an IPO!" honor.

ABOUT XIPTO, INC.

Xipto, Inc. is a mobile advertising company that mobilizes fans, friends, and followers into active marketers through endorsed ringback tones and social media. Xipto provides tools for anyone to find, engage, and reward people who are willing to share specific messages with their friends.

In 2009, Xipto completed the commercial launch of the first Mobile Ringback advertising platform in the US. Xipto’s ring-back ads are endorsed by mobile subscribers, who earn money from the sponsor each time their phone rings and the message is played to their friends, directly prior to live conversations on mobile phones. Xipto also integrates with facebook and twitter to provide a comprehensive social marketing platform that distributes advertiser and advocacy messages into phone conversations and social feeds, where every message posted is associated with someone who supports your brand and wants to share your message.

---

Optical Simulation Software Company Simphotek Announces $ 2M Series A Investment

NEWARK, N.J. (April 154, 2011) -- Simphotek, Inc., developer of a market-changing optical modeling and simulation software that saves time and money by slashing product testing time from years to weeks, received a $2 million Series A investment from Sextant Group, Inc., a private New York City-based investment firm.

Details of the investment are not being made public. However, most of it will be used to grow the company through additions to management, new product development, and marketing and sales initiatives, according to Dr. Mary J. Potasek, Simphotek president.

Simphotek, based in the NJIT’s Enterprise Development Center, is developing a series of photonics software products based on years of work by co-founders Drs. Potasek and Evgueni G. Parilov at various institutions, including Air Force Research Labs and Courant Institute of Mathematical Sciences.

The company’s first product, SimphoSOFT™, is designed to speed up the design of nonlinear active and passive optical materials to days/weeks from the current time of months/years. The long cycle of material fabrication and testing is reduced by SimphoSOFT computer simulation because it allows users to avoid the tedious process of formulating mathematical equations and re-writing simulation in various experimental conditions.

“With its novel CAD technology and easy to use graphical user interface, users do not need to be optics experts or invest heavily in modeling to obtain meaningful photophysical results with SimphoSOFT,” Dr. Potasek said.

The software can be used in myriad industries such as optical communications and biomedicine,  as well as in government for military applications, and in research institutions to rapidly advance new Photonics materials. 

The company is currently beta testing the extensions to the first product to distribute a suite of programs in the United States with plans to expand internationally throughout North America, Europe, and Asia.

Simphotek was formed in 2007 by three experts in the areas of optical modeling, software design, software development and general product development. In addition to Dr. Potasek and Dr. Parilov, who serves as the company’s vice president of research and development, Dr. Karl W. Beeson rounds out the experienced management team as vice president for technology.  The company holds two patents for its software and has been funded through STTR grants and a New Jersey Edison R&D Grant. SimphoSOFT was officially launched in Q1 2011 at Photonics West EXPO in San Francisco, Calif.

---

EDC own Jerry Creighton, Sr. Speaks with NJBIZ about "SPACE"

NJBIZ, April 4, 2011 issue

Jerry Creighton ,Sr., executive director of the Enterprise Development Center, New Jersey's largest incubator and president of NJBIN, spoke with NJBIZ on "Short of space to hatch N.J. startups.

As would-be entrepreneurs try their luck at biotech and high-tech start-ups, it is a little difficult to find office space, that is the right-sized, well-equipped workspace.

The Enterprise Development Center at the New Jersey Institute of Technology, in Newark, has an occupancy rate of 95 percent with 90 companies housed in the incubator, said executive director Jerry Creighton.  Creighton said one key reason for high occupancy rate is the corporate downsizing at Big Pharma, which he said had prompted many within the life sciences industry to strike out on their own. 

"A lot of people do not see a long-term goal of being in a big company in New Jersey, for a variety of reasons," Creighton said. "Therefore, they're becoming entrepreneurs. They want to start their own companies. People want to work for themselves."

One of the EDC's newest start-ups is prominently featured, John Williams, founder and CEO of Health-ISP, a medical data exchange service. Health-ISP is one of 90 companies of the EDC.

---

iSpeech Release DriveSafe.ly on iPhone with Twitter Integration, Surpasses 8 Million Users

March 15, 2011 Newark, NJ and Austin, TX (SXSW) - iSpeech, a leading speech technology provider to developers, announces the launch of DriveSafe.ly on iPhone, the first iOS app to speak text (SMS) messages, emails and Tweets aloud and allow for txt responses by voice.  The launch come on the heels of winning Mashable's Award for 2010 Best Mobile App as well as the 2011 CES Mobile Apps Showdown.  The popular, free app has been used by over 8 million people and has spoken nearly one-half-billion messages to users.

iSpeech technology powers DriveSafe.ly and other apps with human sounding text to speech (TTS) and speech recognition (ASR).  Once activated, it is possible to message via text to speech and voice recognition without touching the phone.  Once an incoming txt message is read aloud, the user can choose to replay the message, speak a response back to the sender or even call back the sender.  DriveSafe.ly is avaiable for iPhone in iTunes App Store, Blackberry in Blackberry App World and in Android Market.

---

         Edge Therapeutics, Inc. Featured in START-UP                                                  

Windhover Information Inc.-windover.com- Vol. 16 No. 3- March 2011

Edge Therapeutics was recently published in START-UP addressing acute brain injuries which is a vexing problem for physicians. Even though there are therapeutic agents available to treat bleeding and other complications resulting from head trama, intracerebral hemorrhage and ruptured brain aneurysms.  However, the effectiveness of these systemic agents is limited because while they may indeed stop bleeding in the brain by promoting therapeutic clotting, these drugs can also cause clotting in the rest of the body. resulting in heart attack or stroke.

Brian Leuthner speaks about the work EDGE Therapeutics is doing to combat such ailments and to help achieve the success the pharmaceutical arena.

About Start-up.

Start-Up: Emerging Medical Ventures: Start-Up is the premier source of business intelligence on the newest companies and emerging technologies. Start-Up is dedicated to helping you find and accurately evaluate real business development, licensing and investment opportunities, more efficiently than you ever imagined possible. In every issue, you get intel on new & emerging technologies; business models; financing strategies; VC and other early stage funding sources; deal profiles; and even tech transfers. Use Start-Up to evaluate future markets, identify and profit from venture opportunities, identify competitive threats and more.

---

Breath Test Detects Radiation

NJIT Magazine-Winter-2011

Menssana Research, Inc., whose laboratory is in the NJIT Enterprise development center, has a $ 4.2 million contract from the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to apply its unique breathalyzer technology to testing for radiation exposure.  If the contract is exercised with options, it could total over $ 22 million.

The breathalyzer system that the company had developed, which is much more sensitive than those used to measure blood alcohol concentrations, can detect several hundred different chemical compounds in samples of human breath. It is currently in studies to identify disease biomarkers for lung cancer, breast cancer and tuberculosis. A pilot study has already identified biomarkers indicating radiation exposure in cancer patients receiving radiation therapy.

Safe, non-evasive and painless, the Messana system requires only that a person breathe gently into a mouthpiece for two minutes.  The project's long-term goal is to develop a point-of-care breathalyzer that could be used to rapidly screen large numbers of people for radiation exposure, and to determine that severity of the doses received.

Contact: Michael Phillips, MD, Menssana Research, Inc 1 Horizon Road, Suite 1415, Fort Lee, Phone and fax: 201 886-7004 www.menssanaresearch.com  

---

Urovalve appoints Brent Johnsen European Managing Director

NEWARK, N.J.--(BUSINESS WIRE)-- Urovalve, a medical device company focused on creating superior products for urinary flow and control, announced today the appointment of Bent Johnsen as European Managing Director, effective immediately,

Mr. Johnsen has extensive experience working with large and small European medical device companies. Most recently, he was CEO of PNN Medical, a company that specializes in minimally invasive medical devices for urology. Previously, he was Corporate Sales and Marketing Director for Unomedical; Partner & Managing Director for Kunde & Co.; and held various positions with Novo Nordisk, including Vice President for U.S. Marketing and Vice President of European Sales.

“Bent will lead Urovalve's market entry into Europe with the launch of our FolEase™ catheter projected for late-2011, followed by the launch of our Surinate® Bladder Management System projected for early-2012,” said Harvey D. Homan, Ph.D., President and CEO of Urovalve.

Urovalve has developed the patent-pending FolEase™ Catheter with Inserter System that is preassembled with a Foley catheter. The system is designed to facilitate insertion of a Foley catheter, especially for difficult situations, such as urethral strictures. FolEase™ is expected to reduce the time required for healthcare professionals to complete insertion of a Foley catheter, reduce the number of instances that require a urologist to be called in to complete an insertion, and be less expensive and simpler to use than other more invasive options that are currently employed.

Urovalve’s flagship product in development is the Surinate® Bladder Management System, designed to eliminate the need for a urine-collection bag or the discomfort and inconvenience of intermittent catheterization. Surinate® is designed with a magnetic valve inside the catheter that allows the bladder to fill and then empty only on manual control by the patient. The patient uses an external magnet to open the valve in the Surinate® catheter to drain the bladder only when he needs to. Furthermore, the Surinate® valved catheter is designed to remain in the patient for up to 30 days. Thus, with Surinate® the patient himself has total control over his bladder-emptying process.

Urovalve, Inc. (www.urovalve.com) is a privately held company located in the Enterprise Development Center at New Jersey Institute of Technology (NJIT) in Newark, New Jersey. The company develops superior medical devices to address problems associated with urinary flow and control.

---

iSpeech Wins Investor Competition at iEvening NJ Conference of 160 NJ Startups

A promising new venture based at the NJIT Enterprise Development Center was selected as the winner at an innovative new business event attended by more than 160 startup founders and entrepreneurs and produced by Sperlingreene PR

FOR IMMEDIATE RELEASE

PRLog (Press Release) – May 25, 2011 – Mayor Cory Booker Is Keynote Speaker at  Conference Hosted By NJIT

A promising new venture based at the NJIT Enterprise Development Center was selected as the winner at iEvening New Jersey, an innovative new business event attended by more than 160 startup founders and entrepreneurs, and hosted by NJIT on May 19, 2011. The four-hour conference included two workshops, networking, 14 exhibits and an investor pitching competition for start-up companies seeking investment capital.

Newark Mayor Cory Booker, delivered a keynote address on innovation and business development at the event, and NJ startups presented competitive speed pitching presentations to a panel of high-profile, early stage investors.

“The success of this event demonstrates the leading role NJIT plays in promoting innovation and entrepreneurial education in the New York metro area,” said Judith Sheft, associate vice president of technology development at NJIT. “Jerry Creighton, executive director of NJIT’s Enterprise Development Center (EDC), continues to foster an environment in which startups can grow and succeed. We expect this will be the first of many events we host.”

The event was produced by iBreakfast New Jersey, a venture of NJ marketing firm, Sperlingreene PR and Marketing, in partnership with New York-based iBreakfast. Attendees heard from a panel of early-stage investors about what they look for in companies in which they invest. The investor panel included: John Ason, angel investor, Stephen Brotman of GSA Venture Partners, Mike Segal of Joshua Capital, and Chris Fralic of First Round Capital.

The winning firm, iSpeech, a profitable provider of cloud-based speech technology and mobile apps, received an invitation to present at the prestigious Private Equity Forum in New York, to be held in June at New York’s Yale Club.  

Sponsors included NJIT, human resource specialist Ambrose, and the law firm Plata Forbes Ferrer & Gutierrez. Event organizers plan ongoing events and meetings sponsored by NJIT, that cater to the New Jersey small business community, including the 95 startup companies based at the NJIT Enterprise Development Center.

Steven Greene, partner of iBreakfastNJ said, “This first iBreakfast event in New Jersey demonstrates the powerful resources available this side of the Hudson, and points to the surging growth of business in the Garden State.” iBreakfast founder, Alan Brody agreed, “We are seeing an exciting new wave of tech and life science ventures emerging from the Garden State.”

iBreakfastNJ is an independent venture of Sperlingreene PR and Marketing in partnership with iBreakfast, the long-standing New York-based digital events organization led by Alan Brody. For additional information and dates of upcoming events, visit www.ibreakfastnj.com.

NJIT’s EDC is home to 95 high-tech and life-science companies. Located on the NJIT campus, EDC companies have access to NJIT facilities and can partner with researchers to help grow their business. EDC is located in the heart of Newark’s University Heights Science Park and the Newark Innovation Zone. For additional information about the EDC visit: http://www.njit-edc.org/

iSpeech Founded in 2007, businesses, organizations and consumers worldwide choose iSpeech for its high quality, scalable and easy to use text-to-speech (TTS), automated speech recognition (ASR) and voice to text solutions. iSpeech's flagship and award winning mobile app, DriveSafe.ly™, has read over 400 million text messages and emails aloud in real-time to over 8 million people. iSpeech® is a privately held company headquartered in Newark, NJ at the NJIT EDC, with offices in San Francisco and New York. For additional information about iSpeech, visit: http://www.ispeech.org/

Sperlingreene PR and Marketing is a communications, public relations and events management firm headed by Karen Sperling and Steven Greene. For additional information, visit www.sperlingreene.com

NJIT, New Jersey's science and technology university, enrolls more than 8,900 students pursuing bachelor's, master's and doctoral degrees in 120 programs. The university consists of six colleges: Newark College of Engineering, College of Architecture and Design, College of Science and Liberal Arts, School of Management, College of Computing Sciences and Albert Dorman Honors College. U.S. News & World Report's 2010 Annual Guide to America's Best Colleges ranked NJIT in the top tier of national research universities. NJIT is internationally recognized for being at the edge in knowledge in architecture, applied mathematics, wireless communications and networking, solar physics, advanced engineered particulate materials, nanotechnology, neural engineering and e-learning. Many courses and certificate programs, as well as graduate degrees, are available online through the Office of Continuing Professional Education.

Contact: Sheryl Weinstein, director, public relations, Sheryl.m.weinstein@njit.edu, 973-596-3436 Karen Sperling/Steven Greene, Sperlingreene PR and Marketing, (201) 543-7421/ (917) 656-1837, ksperling@sperlingreene.com, sgreene@sperlingreene.com.

---

From Brick to Tech City: Venture Capital and University resources to make Newark technology hub

Tuesday, June 14, 2011

Rutgers Center for Urban Entrepreneurship & Economic Development announces partnership with H360 Capital and NJIT aimed at attracting early stage technology firms to Newark

NEWARK, NJ, June 14, 2011 – Building on the momentum created by the White House Urban Entrepreneurship Summit held at Rutgers-Newark on June 6, The Center for Urban Entrepreneurship & Economic Development (CUEED), H360 Capital, a minority-run early stage venture capital firm, and NJIT’s Enterprise Development Center (EDC), announced a partnership to attract technology companies to Newark.

Charlotte-based H360 Capital is a minority-run venture capital firm with a particular focus on companies developing ‘market disrupting’ technologies. Through its “Big Ideas Initiative: B2i,” H360 Capital has committed to investing up to $50,000 in 20 technology start-ups in the Newark area. CUEED and NJIT will provide resources and support to entrepreneurs participating in the Big Ideas program.

“We are working with H360 Capital to help bring many of its current and future portfolio companies to Newark,” said Dr. dt ogilvie, Founding Director of CUEED. “This follows Mayor Cory Booker’s announcement during the Urban Entrepreneurship Summit that he wanted to bring more technology to Newark. We have been working with H360 to shape our relationship to do this and agreed during the White House Summit to form this partnership. One of the stated goals of the partnership is to attract 20 early stage technology firms to this area by 2012, and H360 Capital itself has announced that it is moving its headquarters from North Carolina to the New Jersey/New York region.”

ENTREPRENEURS GATHERED AT THE WHITE HOUSE URBAN ENTREPRENEURSHIP SUMMIT HELD ON JUNE 6 AT RUTGERS-NEWARK. THE CENTER FOR URBAN ENTREPRENEURSHIP & ECONOMIC DEVELOPMENT (CUEED) AT RUTGERS BUSINESS SCHOOL PARTNERED WITH THE OBAMA ADMINISTRATION TO HOST THE EVENT.

  

“We are convinced that this is the right step and will provide the greatest value for technology entrepreneurs we fund,” said Hezekiah Griggs III, Managing Partner of H360 Capital.  “When I formed the thesis for H360 Capital, I wanted it to be able to have a significant impact on a city like Newark by creating a private-public partnership in which all parties are invested in the espousal of innovation as a solution to broad community-related economic concerns. This announcement establishes that we will have a very large footprint in Newark, and we intend to evangelize the vision that all parties share: transforming Newark into an important hub for technology firms over the next 10 years. We are grateful to CUEED Director Dr. dt ogilvie for her efforts.”

“This is a great day for CUEED’s ongoing economic development activities,” said Dr. Jerome Williams, Rutgers Business School Prudential Chair and Research Director of CUEED. “We are exploring a “technology park” joint venture with H360 that could serve as a magnet for other high-tech firms. H360 Capital’s investment activities will spur the kind of entrepreneurial revival that CUEED has been seeking, one that will help bring technology, jobs, and opportunities to Newark.”

Newark,  is home to five Universities—Rutgers-Newark, New Jersey Institute of Technology (NJIT), University of Medicine and Dentistry of New Jersey (UMDNJ), Seton Hall Law School, and Essex Community College—so there is already a strong technology base to build on.

NJIT’s Enterprise Development Center (EDC) has been offering tech and life sciences entrepreneurs training, affordable facilities (offices and laboratories), and access to University and industry collaboration since 1988.

Judith Sheft, Associate Vice President for Technology Development at NJIT, said “The EDC was cited by the Council on Competitiveness as ‘benchmark example of a successful technology-based incubator.’ Cooperation between NJIT, Rutgers, and H360 Capital will help drive Newark to become a new Silicon Valley.” 

About CUEED

The Center for Urban Entrepreneurship & Economic Development (CUEED) at Rutgers Business School is the first center of its kind in the nation to integrate scholarly works with private capital, government, and non-profit sectors to develop citywide resources and bring renewed economic growth and vitality through urban entrepreneurship. CUEED promotes and fosters a new generation of urban entrepreneurs who actively seek socially conscious urban renaissance.

About H360 Capital

H360 Capital is an angel venture capital firm based in NJ/NY area, with regional hubs in Charlotte, NC and Austin, TX. The firm invests in early-stage start-ups with market-disrupting ideas. Innovation is considered key to H360’s investments, as they are typically new ideas that either change a market, or create new markets. Learn more about H360 Capital online at: H360Capital.com

About The Enterprise Development Center at NJIT

The Enterprise Development Center is currently home to over 90 high-tech and life-science companies. It is located within the campus of New Jersey Institute of Technology, New Jersey’s science and technology university. EDC companies have access to NJIT facilities and can partner with researchers to help grow their businesses. The EDC is in the heart of Newark’s University Heights Science Park and the Newark Innovation Zone.

Contacts:

CUEED: The Center for Urban Entrepreneurship & Economic Development Rutgers Business School

1 Washington Park – 10th floor

Newark, NJ 07102

Tel: 973-353-5987

http://business.rutgers.edu/news/2011/06/14/brick-tech-city-venture-capital-and-university-resources-make-newark-technology-hub

---

NJIT's Angel Investment Forum Attracts Creativity, Capital

Friday, October 21, 2011

The intersection of investors, inventors and mentors occurred Friday morning at the New Jersey Institute of Technology, which hosted the 2011 Angel Investor Forum.

"I'm like eHarmony.com — I bring people together," said Gerald Creighton, executive director of NJIT's Enterprise Development Center, during the opening remarks.

Presentations ranged in topics from audio tools to biotechnology applications, and presenters represented every age demographic. What each of the businesses involved in the event had in common was a desire to grow through investment relationships.

The 10-minute presentations demonstrated both competitive advantages and innovative ideas in hopes of gaining funding to increase staff, research and development, and marketing opportunities.

"We're looking for funding, for a long time," said Tekpea Inc. CEO Fabrizio Bertocci, who presented first. "We've been talking to investors, but there are hiccups sometimes. This increases our chances of securing funding."

The 19 companies involved Friday represented a small number of the 91 working with the Enterprise Development Center. Many, while based in the Newark building, have already established footholds in emerging markets — like ATC, which recently opened a subsidiary in India, and Xipto, which is developing contracts with European mobile network providers.

Tekpea, which has created a low-cost energy measurement system for smart grids, has roots in Italy, but is based at the center because "we believe what New Jersey offers, we don't get anywhere else," Bertocci said.

Many of the companies employ fewer than 10, but are anticipating bringing on large marketing staffs as their products grow. Funding requests ranged from the low hundreds of thousands to several million dollars.

---

Jose L. Rodriguez, President & CEO, M.E.R.I.T., Inc., a Client Company located at the Enterprise Development Center (EDC) at NJIT, has been invited to participate in the White House Leader’s Forum on Jobs and Economic Competitiveness on November 4, 2011. The forum will be held in Washington, DC in the White House Eisenhower Executive Office Building. 

Ari A. Matusiak, Executive Director, White House Council, is quoted as follows: “In addition to being “success stories,” you are business leaders in your communities whose feedback, perspective and guidance on jobs and the economy we value”.

Read Invite:

Friends –

I want to thank you for taking the time to share your stories with us about the businesses you are growing and the jobs you are creating.  You are examples to celebrate and lift up, and we look forward to doing so in the weeks ahead.

In addition to being “success stories,” you are business leaders in your communities whose feedback, perspective and guidance on jobs and the economy we value.  To that end, we would like to invite you to join us for a forum on Jobs and Economic Competitiveness at the White House on Friday, November 4, from 9.30am to 4.30pm.  The details about how to RSVP are below.  The invitation is non-transferable, and we very much hope to see you here.

I hope this finds all of you well.  Please do stay in touch.

Best, Ari

Ari A. Matusiak

Executive Director

White House Business Council

---

E-Mail: info@lenterra.com

Lenterra, Inc. Announces Release of RealShear™ Line of Wall Shear Stress Sensors

Newark, NJ – Oct 1, 2011 – Lenterra, Inc. today announced the release of its RealShear™ line of sensors for the direct measurement of wall shear stress. These sensors represent the first commercially available system of their kind in the world. The in-line sensors provide continuous, real-time data measurement rates of up to 1,000 per second with no disruption of process flow. They can also be used to calculate viscosity in combination with known flow parameters. Application areas include industrial mixing, extrusion, and pipelines.When fluids flow along boundaries, or components of mixers rotate inside a fluid, a force is induced between the fluid and the boundary wall that can be represented by two components, one perpendicular to the surface of the boundary and another tangential, or parallel to the surface. The former is known as pressure force, and the latter as shear force. While pressure transducers are readily available commercially for the measurement of the perpendicular force, no sensors for the direct measurement of the shear force, or wall shear stress, are commercially available. Lenterra's novel RealShear™ sensors make it possible to measure the wall shear stress in mixers and extruders in real time. This insight can help process engineers carefully control conditions to consistently produce product with desired properties. Throughput can also be improved by ensuring that no extra or unnecessary mixing is performed. Armed with wall shear stress measurements, engineers can rapidly replicate processes developed in the laboratory on an industrial scale (scale up), thus bringing new products to market faster.  The sensors can also be used in pipeline monitoring applications, where knowledge of the wall shear stress induced on the inner surface of a pipe by liquids or gases passing through it can help flow assurance engineers determine what types of components are present in the flow and also the nature of the flow dynamics. This information can be important in crude oil extraction, helping to estimate the relative amounts of hydrocarbons, water, sand, etc., present, and to predict when it is necessary to replace aging pipelines due to corrosion. “As a physicist with more than 30 years experience, I know first hand that wall shear stress has long been an elusive property to measure, and a long sought after problem in fluid mechanics and related applications.” says Valery Sheverev, President and CEO of Lenterra Inc. “We could estimate it, try to calculate it and make our best guesses, but we could not directly measure it -- until now. After years of development efforts, we are proud to present the first commercially available solution to this problem, in the form of our line of RealShear  which, in combination with known fluid parameters, also provide real time measurement of viscosity, another long-sought after property that, until now, has been difficult to measure in situ. Imagine being able to monitor the real time changes to the properties of a manufactured product – as it is being made. This is now possible with our new line of sensors.” RealShear™ sensors work by using micro-optical resonators to detect minute lateral displacements at the face of the sensor when it experiences shear stress from particles/fluids with which it is in contact. These displacements cause the resonant spectrum of the microoptical resonators to shift, which can be detected by interrogating them with light. Optical controllers that perform the interrogation and communicate measurements with a user’s computer are also available from Lenterra.  Since the RealShear™ sensor system is wholly optical, it is free from electro-magnetic interference, while still operating in a host of environments and particle flows (opaque and translucent, as well as transparent).  The development of wall shear sensors has been supported by the National Science Foundation under the Small Business Innovation Research program.

About Lenterra

Lenterra Inc. is a provider of innovative sensor instrumentation based on a range of patented optical- and plasma-based technologies. The company’s solutions serve a wide range of industries and applications, including pharmaceutical manufacturing, industrial mixing, oil and gas production, and environmental monitoring. RealShear™ is a trademark of Lenterra, Inc.

For additional information, visit www.lenterra.com.

# # #

105 Lock St. Suite 301

Newark, NJ 07103

(973) 623-0755

---

Marjorie A. Perry receives NJIT Alumni Achievement Award

October 17th, 2011 Marjorie Perry, president and CEO of MZM Construction and Management, a Newark-based company, recently received one of six annual NJIT Alumni Achievement Awards. Perry oversees an enterprise whose projects span transportation facilities, schools, entertainment venues and residences. Diverse experiences have contributed to Perry's achieving this position — experiences that include selling sandpaper, a conversation with clothing designer Ralph Lauren, and completing her MBA from the NJIT School of Management in 2005.

But there's a common thread of purpose in all that Perry has done. Communicating irrepressible energy and enthusiasm, she says, "I always focus on learning whatever is needed to navigate in any waters where I might find myself."

During Perry's tenure at MZM, she has learned what it takes to navigate toward success in full-service construction management, and to branch out into areas such as bio-solid waste transportation, as described at http://www.mzmcc.com. The course she followed to arrive at this executive destination began in 1974 with a degree in education from Kean College and a teaching job with the Newark public school system. Upon losing that job in a round of layoffs, she had to ask herself: "What can I do next?"

The answer was to move on to sales and marketing, a good match for her personality. This led to joining 3M, and later Johnson & Johnson and United Airlines. It was when Perry was with 3M that she sold sandpaper to clients in the Midwest. "Working for each of these world-class companies was like being in a mini-MBA program," Perry says of how they helped to hone her business acumen.

Bringing her skills to United Airlines when the airline industry was deregulated in the 1980s, she enjoyed first-class global travel. On flights to Hong Kong, Tokyo and other distant cities, conversations with businessmen — and Perry emphasizes that they were virtually all men in those days — caused her to think seriously about her own entrepreneurial inclinations.

Perry cites one conversation in particular. It was with Ralph Lauren, who spoke about the exciting challenges of starting a business and the positive difference that individuals willing to take the chance can make in the world. "I can do that," she decided.

In 1986, Perry launched a consulting company focused on helping nascent entrepreneurs, including women and minorities, succeed in the marketplace. Two clients, young engineers, asked her to get their construction company off the ground. She subsequently became a partner in the firm. The company was MZM. In 1994, she became the sole principal.

Perry says that she had a lot to learn, and proceeded to do so by taking courses at Rutgers, Stevens, NYU and NJIT. She augmented her already considerable background in business with new knowledge of engineering theory, project management, and hands-on basics like learning how to read a blueprint. Eventually, feeling the the need to gain the benefits of an MBA, she applied to schools that included Columbia, Dartmouth and Harvard, and was accepted by all of them. However, given the unique technological context of NJIT's program , Perry concluded that her future — and that of MZM — would best be served by studying for the degree at the School of Management in Newark. "It was definitely the place I wanted to be," she says.

Perry also manages to find the time to share her experiences and insights with women's groups, civic organizations and on television. Additionally, she returned to the classroom at NJIT last spring as an instructor, teaching Principles of Management. Whether speaking at the Governor's Conference for Women, on the TV show NJ Caucus or to NJIT students, her optimism about personal and entrepreneurial possibility conveys a consistent message: "You, too, can do it."

Provided by New Jersey Institute of Technology

---

Leading Edge, Solar Parking Lot Systems Firm, Wattlots LLC, Receives Major Technology Award

The New Jersey Technology Council (NJTC) named Wattlots LLC, of Millington, as one of the winners of its coveted, mid-Atlantic Innovation Competition during a conference recently held at New York Internet Co.’s Bridgewater offices. Key criteria in the nomination and award process is whether the winner represents an innovative and ground-breaking technology, or design approach, which can change the way things are currently done.

WattLots LLC, which competed in the electronics/advanced materials category, presented its advanced Solar Arbor Systems. The Solar Power Arbors™ are equipped with WattLots LLC’s proprietary LiteBeam™ design solar modules. Both the Power Arbor™ and the LiteBeams™ represent a clear and striking break from the way in which parking solar installations have been done in the past. Gone are the days of dull, monolithic, and ugly solar parking lot structures.

WattLots LLC’s CEO William Kaufman believes that the product’s unique design answers a number of issues, which plague conventional parking lot structures-from aesthetics to efficiency. Mr. Kaufman points out the many advances The Power Arbor™ represents, “as a uniquely styled parking lot canopy system that is specifically designed to retrofit existing surface parking lots, The Power Arbor™ will provide substantial quantities of clean, renewable electrical energy at the source of demand where it is needed. The Wattlots Power Arbors™ are not passive or static. Unlike other parking lot solar structures, Power Arbors™ incorporate additional technologies, which will make them able to relay, real-time data to Wattlots scientists, so as to improve learning.” Kaufman also points out that the Power Arbors™ rotate and follow the sun. This unique feature, “greatly increases energy gathering efficiency.”

The solar technology being implemented is the most reliable and highest efficiency technology known; silicon mono-crystalline cells. Kaufman is confident of success for his company. “This technology provides the highest power output per area occupied of any known solar technologies worldwide. Its open-air design does not collect snow, making it perfect for Northeast Corridor lots. The structures are manufactured and assembled in New Jersey. I believe that Wattlots will provide over 1,000 jobs to NJ.”

Mr. Kaufman’s firm belief that New Jersey is the right place for advanced and innovative solar-technology companies such as Wattlots, is shared by not only the award-givers, the New Jersey Technology Council (NJTC) but also by NJ’s BPU, which awarded Wattlots the Edison Clean Energy Grant and by the NJIT Enterprise Development Center (EDC), which has formed an association with Wattltots.

For more information on this award, and WattLotts LLC, please visit www.wattlots.com or call us at 877 WATTLOTS.

11/21/11

---

Edge Therapeutics Receives Success Award From New Jersey Small Business Development Centers

NEW PROVIDENCE, NJ--(Marketwire - December 02, 2011) - Edge Therapeutics, Inc. announced today that the New Jersey Small Business Development Centers (NJSBDC) has named Edge a recipient of its 2011 Success Awards. The award recognizes companies and legislators for their commitment to the growth of small businesses representing a diverse array of industries including biotechnology, financial services, educational services, media and entertainment, food services and high-tech.

"Edge is a great example of what's possible when talented and capable entrepreneurs apply their skills to a unique and innovative idea," said Jerry Creighton, Sr., Executive Director of the NJIT-EDC. "The outcome is an emerging growth company! Everyone wins when you advance new scientific research."

Edge Therapeutics is a hospital-focused biopharmaceutical company developing novel implantable technology for direct delivery of proven drugs to the site of brain injury. Edge began in 2009 as a New Jersey Institute of Technology Enterprise Development Center (NJIT-EDC) incubator company and has recently moved into its new commercial headquarters in New Providence, NJ.

"We are honored to be the recipient of a 2011 NJSBDC Success Award. It is a tremendous validation of the rapid progress we are making in developing life-saving therapies for civilians and soldiers that suffer brain hemorrhages," said Brian Leuthner, President and Chief Executive Officer of Edge. "The New Jersey Small Business Development Centers along with the NJIT-EDC have been a vital resource for Edge as we grow."

"Under the leadership of Brian Leuthner, Edge has grown rapidly with the support of non-dilutive partner funds and by securing equity financing," noted Randy Harmon, New Jersey Small Business Development Centers Lead Technology Commercialization Consultant.

About Edge Therapeutics

Edge Therapeutics uses a novel, site-specific and sustained release-microparticle technology platform to deliver drugs to the brain and treat acute, and fatal or debilitating neurological conditions that currently have no effective therapies. Edge works with some of the world's foremost scientists from leading academic research centers to develop proprietary and novel formulations of known active drugs for direct therapeutic delivery to the site of injury in the brain.

The company's patent-protected, bioabsorbable microparticle formulations release drugs locally and consistently at therapeutic concentrations in the brain, which maximizes therapeutic activity while avoiding treatment-limiting systemic side effects seen with oral and intravenous delivery. This technology platform is the basis of Edge's pipeline of drugs in therapeutic areas such as complications from spontaneous brain hemorrhage, traumatic brain injury and brain surgery. The lead products, NimoGel™ and NimoVent™, are microparticle formulations of the calcium channel blocker nimodipine. These drugs are being developed to prevent delayed complications after subarachnoid hemorrhage (where today oral- or i.v.-administered nimodipine is employed but in suboptimal concentrations due to the generation of systemic side effects). Phase 2 studies for both NimoGel and NimoVent are planned for 2012.

For more information on Edge Therapeutics, Inc., please visit www.edgetherapeutics.com.

Contact:

Edge Therapeutics, Inc.

Brian A. Leuthner

President & CEO

800-208-EDGE

---

NJBIZ Honors New Jersey’s Best 50 Women in Business

Linda C. Sharkus, Ph.D., President and Co-Founder of AcquiSci Inc., has been named one of New Jersey’s 2012 Best 50 Women in Business. The award program, produced by NJBIZ, New Jersey’s premiere business news publication, is sponsored by Wells Fargo, WithumSmith+Brown, PC and Wolff & Samson PC.

The Best 50 Women in Business awards program honors New Jersey’s most dynamic women in business that have been making headlines in their field. To qualify, a nominee had to meet selection criteria that included living or working in New Jersey and holding significant authority for decision making in a for-profit company. 

An independent panel of judges selected the top 50 winners based on their dedication to business growth, professional and personal accomplishments, community involvement, and advocacy for women.

“We are truly fortunate to have the opportunity to recognize this outstanding group of women.” said Thomas Curtin, publisher of NJBIZ.  “As business and community leaders, they are constantly redefining success within and outside the business arena.  On behalf of NJBIZ, we would like to thank and congratulate these fifty outstanding women for their dedication to New Jersey’s future.”

NJBIZ and the program sponsors will honor this year’s winners during an awards ceremony on Tuesday, March 27, 2012 at The Palace at Somerset in Somerset, NJ.  The honorees will also be highlighted in a special supplement to NJBIZ on April 2, 2012.

ABOUT:

AcquiSci’s medical device technology platform represents a novel process that reduces inflammation and widens the window for treatment after incidence of stroke. AcquiSci is located at the Enterprise Development Center, a high-tech business incubator at the New Jersey Institute of Technology in Newark. For more information, visit www.acquisci.com

---

EDC Client Company Selected as "New Jersey's State Small Business Person of the YEAR!"

Ms. Marjorie A. Perry, President & CEO of MZM Construction Company, Inc. and a portfolio company of the EDC at NJIT has been selected by the U.S. Small Business Administration (SBA) as the 2012 New Jersey State Small Business Person of the Year. As an award winner she is invited to attend the National Small Business Week celebration to be held in Washington, DC May 20-22, 2012.

---

Congratulations to Three Award Winners at the NJTC Venture Conference

Congratulations to the three companies from the EDC that won honors at the NJTC Venture Conference on March 22nd.

• Endomedix, Inc for the Best Life Science Company
• ATC Labs for Best Communications Company
• Allweb Technologies for Best Information Technologies Company

---

AcquiSci Receives Award from Hackensack University Medical Center to Research Company’s Patented Anti-Inflammatory d-OSAB™ Technology 

AcquiSci and Hackensack University Medical Center to Collaborate on Investigating the Therapeutic Potential of the d-OSAB Medical Device-Based Anti-Inflammatory Platform Technology in a Preclinical Stroke Study Program

NEWARK, NJ --(June 11, 2012) - AcquiSci Inc., www.acquisci.com, an NJIT-Enterprise Development Center (NJIT-EDC) incubator company; today announced it has received an award from the Hackensack University Medical Center to research AcquiSci’s patented d-OSAB™ technology as a device-based approach to modulating inflammation.  This preclinical study represents Phase I of a three Phase study program, and will evaluate the safety and efficacy of oxidative stress on apoptotic leukocyte induction and subsequent inflammatory cytokine modulation.  The overall program is designed to transition into a clinical stroke porcine model with primary clinical endpoints paralleling those typical in a human efficacy trial for translational relevance.  This project is being funded by the U.S. Department of Defense in support of development of candidate treatment approaches for traumatic brain injury resulting from military operations.

Dr. Chinwe Ogedegbe, Section Chief, Research Emergency Trauma Department at HackensackUMC, will be the Principal Investigator.   AcquiSci will work closely with HackensackUMC by participating in the study design and investigator meetings.

AcquiSci’s CEO and inventor of the technology, Joseph Latino, stated “This is an excellent opportunity to rigorously confirm the ability of AcquiSci’s technology to reduce inflammation that is the underpinning of many diseases, in particular, traumatic brain injury.  Using the porcine stroke model, we believe that we can conclusively demonstrate a reduction in the inflammation surrounding the clot commonly attributed as a major causative phenomenon resulting in loss of cognitive and motor function loss in ischemic stroke.  Positive results in inflammation reduction in stroke modeling may be applied to traumatic brain injury and in particular, useful in military applications. HackensackUMC recognized the importance of this common inflammatory component and we are fortunate to have been able to establish this noteworthy affiliation.”

About Hackensack University Medical Center

Hackensack University Medical Center, a 775-bed teaching and research hospital affiliated with the University of Medicine and Dentistry of New Jersey -- New Jersey Medical School, is the largest provider of inpatient and outpatient services in the state of New Jersey. Founded in 1888 with 12 beds and as Bergen County's first hospital, Hackensack University Medical Center has demonstrated more than a century of growth and progress. Today, this not-for-profit, tertiary-care, teaching and research hospital serves as the hub of healthcare for northern New Jersey and the New York metropolitan area. Hackensack University Medical Center continues to grow in response to the needs of its patient population.

About AcquiSci

AcquiSci Inc., a privately-held New Jersey corporation, incorporated in December 2007, is developing its medical device-based technology with an anti-inflammatory therapeutic platform known as d-OSAB™ (doseable-Oxidative Stressed Autologous Blood) that will appreciably widen the present window of treatment for ischemic stroke.  The device has applications for other clinical indications, including Chronic Heart Failure, where inflammation is an underlying cause of disease, and as a purification process for the production of pathogen-free biologics, i.e. the inactivation of infectious prions, the rogue protein attributed to Mad Cow and Creutzfeldt-Jakob diseases.

For inquiries, please contact:

Truphone Establishes Technology Center in New Jersey

to Support Company’s Expansion in U.S.

Broader nationwide presence enables delivery

of innovative mobile services for business customers

---

Truphone Establishes Technology Center in New Jersey

to Support Company’s Expansion in U.S.

                           Broader nationwide presence enables delivery of innovative mobile services for business customers

NEWARK, N.J., Aug. 30, 2012 – Truphone, the pioneering international mobile communications company, today announced the establishment of a Technology Center.  The New Jersey center complements Truphone’s United States headquarters in North Carolina’s Research Triangle Park.

The technology center is led by Ed Guy, Ph.D., Vice President of Engineering, and Chris Celiberti, Vice President of Business Engineering. They and their staff of computer and communications engineers are responsible for developing innovative mobile services for the global business market. Both report to Truphone founder and Chief Technology Officer James Tagg.

Located in the Enterprise Development Center at the New Jersey Institute of Technology (NJIT) in Newark, the Truphone technology center initially consists of a staff of 12, many of whom are NJIT graduates. 

Guy, who has worked with Truphone since the company’s earliest days, designed and led the implementation of its network as it evolved from a mobile VoIP provider into a full-fledged global mobile operator capable of connecting voice, data and text messaging to more than 200 countries.

Guy developed the original architecture for many of today’s VoIP systems and is author of patents and essential documents that specify how the Internet works. “Our mission is to develop Truphone’s patent portfolio and turn these into new and innovative services that people need, can’t live without, and can’t obtain elsewhere,” he said.

Tagg said:  “We are seeing incredible demand for Truphone’s solutions from U.S.-based multi-nationals, and we are expanding our U.S. operations and engineering staff to meet that demand and add to our innovation portfolio. International business travelers want to stay connected on the road. Truphone allows them to do just that, with the same mobile phone experience they enjoy at home but without fear of bill shock when they roam internationally.”

Mobile users who switch to Truphone no longer need to carry multiple phones, change SIM cards or stop using their phones when traveling. Truphone offers a complete solution for use at home and abroad.

Founded by Tagg, Truphone began on a farm in Kent, U.K., in 2006 with a handful of people and a big idea to break down the barriers to effective global mobile communications.  Now, with global headquarters in London, and additional operations in Australia, Hong Kong, the Netherlands, Portugal and the U.S., the company has grown to employ approximately 350 people worldwide.

Truphone initially gained attention in 2006 with the introduction of the world’s first mobile VoIP application. In 2007, it made history by demonstrating the first VoIP application on the Apple iPhone before launching a string of industry firsts starting in 2008 with applications for Apple’s iPhone, iPad and the Google Android line of smartphones.  Truphone has since expanded its offerings to include GSM-based voice, text and data mobile services, which will soon be available in the United States.

#    #    #

About Truphone

Truphone is a global mobile operator, helping people and businesses around the world stay connected, wherever they may be.

About NJIT’s EDC

Since 1988, the Enterprise Development Center (EDC) operated by New Jersey Institute of Technology (NJIT) has been instrumental in the development and the commercialization of High Tech and Life Science companies.  Residence at the EDC is open to venture and expansion companies that have, or will have, proprietary technology as a significant source of revenue.

---

AcquiSci Received Award from Hackensack University Medical Center to Research Company's Patented Anti-Inflammatory d-OSAB™ Technology

---

Innovative Solar Parking Lot System Installed at Runnells Hospital

Millington, NJ January 15, 2013-- WattLots LLC announced today that it has completed the installation of the ground breaking "Power Arbor"™ parking lot system at Runnells Specialized Hospital in Berkeley Heights, NJ. The WattLots Solar Power Power Arbors™ represent a clear and striking break from the parking solar installation delivering 160,000 kilowatt hours of clean power from the sun annually.  The installation will save the hospital $ 1.7 million and reduce carbon emissions by 3,300 tons over the life of the system was installed by EMSA Solar and funded by a Union County Federal Stimulus Fund Grant.

"The product's unique design answers a number of issues which plague conventional parking lot structures" said WattLots' CEO, William Kaufman. "The Power Arbor™ provides a uniquely styled parking lot canopy system that is specifically designed for the northeastern climate" The Power Arbor™ provides substantial quantities of clean, renewable electrical energy at the sources of demand where it is needed and it automatically rotates and follows the sun increasing energy generation by up to 40 %.

The system uses silicon mono-crystalline solar cells which are the most reliable and highest efficiency technology available. They provide the highest power output per area occupied of any known solar technologies worldwide. Unlike other flat panel systems, its open-air design does not collect snow which provides up to 60 more days of operation per year, making it perfect for Northeast Corridor lots or regions with regular snowfall. The structures are manufactures and assembled in New Jersey.

“This solar installation represents another step forward for Union County as we transition toward new energy technologies that are cleaner, safer, healthier and that save money, too,” said Freeholder Chairman Linda Carter. “We are very proud that Union County is helping to ensure that New Jersey continues its national leadership role in the solar energy field.”    

About WattLots

WATTLOTS LLC was founded in 2009 by William Kaufman.  He has received numerous awards including “Architect of the Year” and “Top 40 Entrepreneurs under the age of 40” and is New Jersey’s first LEED™ accredited architect.   The company’s mission is to bring the solar industry, “game changing” design innovations seamlessly incorporating the latest solar technology available to meet the growing demands of the industry.  WATTLOTS LLC is proud to be an active member of the New Jersey Institute of Technology Enterprise Development Center.  For more information on and WattLots LLC, please visit www.wattlots.com or contact Chris Connor at (908) 626-1555